APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical and Biopharmaceutical Safety Testing Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Outlook and Growth Opportunities 2026

12 August 2026218 pages

Choose your research edition.

Industry ResearchPharmaceutical and Biopharmaceutical Safety Testing Service Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Pharmaceutical and Biopharmaceutical Safety Testing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical and Biopharmaceutical Safety Testing Service Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical and Biopharmaceutical Safety Testing Service Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Pharmaceutical and Biopharmaceutical Safety Testing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmaceutical and Biopharmaceutical Safety Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical and Biopharmaceutical Safety Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical and Biopharmaceutical Safety Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmaceutical and Biopharmaceutical Safety Testing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmaceutical and Biopharmaceutical Safety Testing Service market include Eurofins Scientific, SGS, Q2 Solutions, Samsung Biologics, Texcell, WuXi Biologics, Wuhan Canvest Biotechnology, Centre Testing International (CTI) and Suzhou Liangchen Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pharmaceutical and Biopharmaceutical Safety Testing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical and Biopharmaceutical Safety Testing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical and Biopharmaceutical Safety Testing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmaceutical and Biopharmaceutical Safety Testing Service market.

Pharmaceutical and Biopharmaceutical Safety Testing Service Segment by Company

Eurofins Scientific

SGS

Q2 Solutions

Samsung Biologics

Texcell

WuXi Biologics

Wuhan Canvest Biotechnology

Centre Testing International (CTI)

Suzhou Liangchen Biotechnology

JADE Biomedical

Standard Testing Group

Sino Tech World Biologicals

CAS Testing Technical Services

NTEK

Sino Biological

Miracle Points

Suzhou Cefety Bioscience

Zhejiang Hengyu Biological

Merck

Charles River Laboratories

Sartorius

Pharmaceutical and Biopharmaceutical Safety Testing Service Segment by Type

Raw Materials

Viral Banks

Cell Banks

Others

Pharmaceutical and Biopharmaceutical Safety Testing Service Segment by Application

Pharmaceutical and Biotechnology Companies

CROs and CDMOs

Academic and Research Institutions

Pharmaceutical and Biopharmaceutical Safety Testing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmaceutical and Biopharmaceutical Safety Testing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pharmaceutical and Biopharmaceutical Safety Testing Service key companies, revenue, market share, and recent developments.

3. To split the Pharmaceutical and Biopharmaceutical Safety Testing Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pharmaceutical and Biopharmaceutical Safety Testing Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmaceutical and Biopharmaceutical Safety Testing Service significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmaceutical and Biopharmaceutical Safety Testing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical and Biopharmaceutical Safety Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical and Biopharmaceutical Safety Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical and Biopharmaceutical Safety Testing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical and Biopharmaceutical Safety Testing Service industry.

Chapter 3: Detailed analysis of Pharmaceutical and Biopharmaceutical Safety Testing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pharmaceutical and Biopharmaceutical Safety Testing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pharmaceutical and Biopharmaceutical Safety Testing Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Trends Table 2. Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Drivers Table 3. Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Opportunities and Challenges Table 4. Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Restraints Table 5. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue Share by Company (2021-2026) Table 7. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Key Company Manufacturing Base & Headquarters Table 9. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Company, Product Type & Application Table 10. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pharmaceutical and Biopharmaceutical Safety Testing Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Raw Materials Table 15. Significant Companies of Viral Banks Table 16. Significant Companies of Cell Banks Table 17. Significant Companies of Others Table 18. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type (2021-2026) Table 22. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Pharmaceutical and Biotechnology Companies Table 24. Significant Companies of CROs and CDMOs Table 25. Significant Companies of Academic and Research Institutions Table 26. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application (2021-2026) Table 30. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application (2027-2032) Table 31. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Region (2021-2026) Table 34. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Region (2027-2032) Table 36. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Market Share by Country (2021-2026) Table 39. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Market Share by Country (2027-2032) Table 41. Eurofins Scientific Company Information Table 42. Eurofins Scientific Business Overview Table 43. Eurofins Scientific Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Eurofins Scientific Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 45. Eurofins Scientific Recent Development Table 46. SGS Company Information Table 47. SGS Business Overview Table 48. SGS Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. SGS Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 50. SGS Recent Development Table 51. Q2 Solutions Company Information Table 52. Q2 Solutions Business Overview Table 53. Q2 Solutions Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Q2 Solutions Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 55. Q2 Solutions Recent Development Table 56. Samsung Biologics Company Information Table 57. Samsung Biologics Business Overview Table 58. Samsung Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Samsung Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 60. Samsung Biologics Recent Development Table 61. Texcell Company Information Table 62. Texcell Business Overview Table 63. Texcell Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Texcell Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 65. Texcell Recent Development Table 66. WuXi Biologics Company Information Table 67. WuXi Biologics Business Overview Table 68. WuXi Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. WuXi Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 70. WuXi Biologics Recent Development Table 71. Wuhan Canvest Biotechnology Company Information Table 72. Wuhan Canvest Biotechnology Business Overview Table 73. Wuhan Canvest Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Wuhan Canvest Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 75. Wuhan Canvest Biotechnology Recent Development Table 76. Centre Testing International (CTI) Company Information Table 77. Centre Testing International (CTI) Business Overview Table 78. Centre Testing International (CTI) Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Centre Testing International (CTI) Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 80. Centre Testing International (CTI) Recent Development Table 81. Suzhou Liangchen Biotechnology Company Information Table 82. Suzhou Liangchen Biotechnology Business Overview Table 83. Suzhou Liangchen Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Suzhou Liangchen Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 85. Suzhou Liangchen Biotechnology Recent Development Table 86. JADE Biomedical Company Information Table 87. JADE Biomedical Business Overview Table 88. JADE Biomedical Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. JADE Biomedical Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 90. JADE Biomedical Recent Development Table 91. Standard Testing Group Company Information Table 92. Standard Testing Group Business Overview Table 93. Standard Testing Group Pharmaceutical and Biopharmaceutical Safety Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Standard Testing Group Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 95. Standard Testing Group Recent Development Table 96. Sino Tech World Biologicals Company Information Table 97. Sino Tech World Biologicals Business Overview Table 98. Sino Tech World Biologicals Pharmaceutical and Biopharmaceutical Safety Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Sino Tech World Biologicals Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 100. Sino Tech World Biologicals Recent Development Table 101. CAS Testing Technical Services Company Information Table 102. CAS Testing Technical Services Business Overview Table 103. CAS Testing Technical Services Pharmaceutical and Biopharmaceutical Safety Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. CAS Testing Technical Services Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 105. CAS Testing Technical Services Recent Development Table 106. NTEK Company Information Table 107. NTEK Business Overview Table 108. NTEK Pharmaceutical and Biopharmaceutical Safety Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. NTEK Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 110. NTEK Recent Development Table 111. Sino Biological Company Information Table 112. Sino Biological Business Overview Table 113. Sino Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Sino Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 115. Sino Biological Recent Development Table 116. Miracle Points Company Information Table 117. Miracle Points Business Overview Table 118. Miracle Points Pharmaceutical and Biopharmaceutical Safety Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Miracle Points Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 120. Miracle Points Recent Development Table 121. Suzhou Cefety Bioscience Company Information Table 122. Suzhou Cefety Bioscience Business Overview Table 123. Suzhou Cefety Bioscience Pharmaceutical and Biopharmaceutical Safety Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Suzhou Cefety Bioscience Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 125. Suzhou Cefety Bioscience Recent Development Table 126. Zhejiang Hengyu Biological Company Information Table 127. Zhejiang Hengyu Biological Business Overview Table 128. Zhejiang Hengyu Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Zhejiang Hengyu Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 130. Zhejiang Hengyu Biological Recent Development Table 131. Merck Company Information Table 132. Merck Business Overview Table 133. Merck Pharmaceutical and Biopharmaceutical Safety Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Merck Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 135. Merck Recent Development Table 136. Charles River Laboratories Company Information Table 137. Charles River Laboratories Business Overview Table 138. Charles River Laboratories Pharmaceutical and Biopharmaceutical Safety Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Charles River Laboratories Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 140. Charles River Laboratories Recent Development Table 141. Sartorius Company Information Table 142. Sartorius Business Overview Table 143. Sartorius Pharmaceutical and Biopharmaceutical Safety Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Sartorius Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio Table 145. Sartorius Recent Development Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Pharmaceutical and Biopharmaceutical Safety Testing Service Product Image Figure 2. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Raw Materials Image Figure 8. Viral Banks Image Figure 9. Cell Banks Image Figure 10. Others Image Figure 11. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type (2021-2032) Figure 14. Pharmaceutical and Biotechnology Companies Image Figure 15. CROs and CDMOs Image Figure 16. Academic and Research Institutions Image Figure 17. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application (2021-2032) Figure 20. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value (2021-2032) & (US$ Million) Figure 23. North America Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value (2021-2032) & (US$ Million) Figure 29. South America Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Raw Materials
  • Viral Banks
  • Cell Banks
  • Others
Applications
  • Pharmaceutical and Biotechnology Companies
  • CROs and CDMOs
  • Academic and Research Institutions
Companies covered
  • Eurofins Scientific
  • SGS
  • Q2 Solutions
  • Samsung Biologics
  • Texcell
  • WuXi Biologics
  • Wuhan Canvest Biotechnology
  • Centre Testing International (CTI)
  • Suzhou Liangchen Biotechnology
  • JADE Biomedical
  • Standard Testing Group
  • Sino Tech World Biologicals
  • CAS Testing Technical Services
  • NTEK
  • Sino Biological
  • Miracle Points
  • Suzhou Cefety Bioscience
  • Zhejiang Hengyu Biological
  • Merck
  • Charles River Laboratories
  • Sartorius

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pharmaceutical and Biopharmaceutical Safety Testing Service Market Dynamics
  1. 2.1 Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Trends
  2. 2.2 Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Drivers
  3. 2.3 Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Restraints
3 Pharmaceutical and Biopharmaceutical Safety Testing Service Market by Company
  1. 3.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Company Revenue Ranking in 2025
  2. 3.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue by Company (2021-2026)
  3. 3.3 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Company Ranking (2024-2026)
  4. 3.4 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Company Product Type and Application
  6. 3.6 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pharmaceutical and Biopharmaceutical Safety Testing Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pharmaceutical and Biopharmaceutical Safety Testing Service Market by Type
  1. 4.1 Pharmaceutical and Biopharmaceutical Safety Testing Service Type Introduction
  2. 4.1.1 Raw Materials
  3. 4.1.2 Viral Banks
  4. 4.1.3 Cell Banks
  5. 4.1.4 Others
  6. 4.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value by Type
  7. 4.2.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value by Type (2021-2032)
  9. 4.2.3 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type (2021-2032)
5 Pharmaceutical and Biopharmaceutical Safety Testing Service Market by Application
  1. 5.1 Pharmaceutical and Biopharmaceutical Safety Testing Service Application Introduction
  2. 5.1.1 Pharmaceutical and Biotechnology Companies
  3. 5.1.2 CROs and CDMOs
  4. 5.1.3 Academic and Research Institutions
  5. 5.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value by Application
  6. 5.2.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value by Application (2021-2032)
  8. 5.2.3 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application (2021-2032)
6 Pharmaceutical and Biopharmaceutical Safety Testing Service Regional Value Analysis
  1. 6.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value (2021-2032)
  7. 6.3.2 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value (2021-2032)
  10. 6.4.2 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value (2021-2032)
  16. 6.6.2 South America Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical and Biopharmaceutical Safety Testing Service Country-level Value Analysis
  1. 7.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pharmaceutical and Biopharmaceutical Safety Testing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eurofins Scientific
  2. 8.1.1 Eurofins Scientific Company Information
  3. 8.1.2 Eurofins Scientific Business Overview
  4. 8.1.3 Eurofins Scientific Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eurofins Scientific Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  6. 8.1.5 Eurofins Scientific Recent Developments
  7. 8.2 SGS
  8. 8.2.1 SGS Company Information
  9. 8.2.2 SGS Business Overview
  10. 8.2.3 SGS Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 SGS Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  12. 8.2.5 SGS Recent Developments
  13. 8.3 Q2 Solutions
  14. 8.3.1 Q2 Solutions Company Information
  15. 8.3.2 Q2 Solutions Business Overview
  16. 8.3.3 Q2 Solutions Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Q2 Solutions Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  18. 8.3.5 Q2 Solutions Recent Developments
  19. 8.4 Samsung Biologics
  20. 8.4.1 Samsung Biologics Company Information
  21. 8.4.2 Samsung Biologics Business Overview
  22. 8.4.3 Samsung Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Samsung Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  24. 8.4.5 Samsung Biologics Recent Developments
  25. 8.5 Texcell
  26. 8.5.1 Texcell Company Information
  27. 8.5.2 Texcell Business Overview
  28. 8.5.3 Texcell Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Texcell Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  30. 8.5.5 Texcell Recent Developments
  31. 8.6 WuXi Biologics
  32. 8.6.1 WuXi Biologics Company Information
  33. 8.6.2 WuXi Biologics Business Overview
  34. 8.6.3 WuXi Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 WuXi Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  36. 8.6.5 WuXi Biologics Recent Developments
  37. 8.7 Wuhan Canvest Biotechnology
  38. 8.7.1 Wuhan Canvest Biotechnology Company Information
  39. 8.7.2 Wuhan Canvest Biotechnology Business Overview
  40. 8.7.3 Wuhan Canvest Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Wuhan Canvest Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  42. 8.7.5 Wuhan Canvest Biotechnology Recent Developments
  43. 8.8 Centre Testing International (CTI)
  44. 8.8.1 Centre Testing International (CTI) Company Information
  45. 8.8.2 Centre Testing International (CTI) Business Overview
  46. 8.8.3 Centre Testing International (CTI) Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Centre Testing International (CTI) Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  48. 8.8.5 Centre Testing International (CTI) Recent Developments
  49. 8.9 Suzhou Liangchen Biotechnology
  50. 8.9.1 Suzhou Liangchen Biotechnology Company Information
  51. 8.9.2 Suzhou Liangchen Biotechnology Business Overview
  52. 8.9.3 Suzhou Liangchen Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Suzhou Liangchen Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  54. 8.9.5 Suzhou Liangchen Biotechnology Recent Developments
  55. 8.10 JADE Biomedical
  56. 8.10.1 JADE Biomedical Company Information
  57. 8.10.2 JADE Biomedical Business Overview
  58. 8.10.3 JADE Biomedical Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 JADE Biomedical Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  60. 8.10.5 JADE Biomedical Recent Developments
  61. 8.11 Standard Testing Group
  62. 8.11.1 Standard Testing Group Company Information
  63. 8.11.2 Standard Testing Group Business Overview
  64. 8.11.3 Standard Testing Group Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Standard Testing Group Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  66. 8.11.5 Standard Testing Group Recent Developments
  67. 8.12 Sino Tech World Biologicals
  68. 8.12.1 Sino Tech World Biologicals Company Information
  69. 8.12.2 Sino Tech World Biologicals Business Overview
  70. 8.12.3 Sino Tech World Biologicals Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Sino Tech World Biologicals Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  72. 8.12.5 Sino Tech World Biologicals Recent Developments
  73. 8.13 CAS Testing Technical Services
  74. 8.13.1 CAS Testing Technical Services Company Information
  75. 8.13.2 CAS Testing Technical Services Business Overview
  76. 8.13.3 CAS Testing Technical Services Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 CAS Testing Technical Services Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  78. 8.13.5 CAS Testing Technical Services Recent Developments
  79. 8.14 NTEK
  80. 8.14.1 NTEK Company Information
  81. 8.14.2 NTEK Business Overview
  82. 8.14.3 NTEK Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 NTEK Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  84. 8.14.5 NTEK Recent Developments
  85. 8.15 Sino Biological
  86. 8.15.1 Sino Biological Company Information
  87. 8.15.2 Sino Biological Business Overview
  88. 8.15.3 Sino Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Sino Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  90. 8.15.5 Sino Biological Recent Developments
  91. 8.16 Miracle Points
  92. 8.16.1 Miracle Points Company Information
  93. 8.16.2 Miracle Points Business Overview
  94. 8.16.3 Miracle Points Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Miracle Points Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  96. 8.16.5 Miracle Points Recent Developments
  97. 8.17 Suzhou Cefety Bioscience
  98. 8.17.1 Suzhou Cefety Bioscience Company Information
  99. 8.17.2 Suzhou Cefety Bioscience Business Overview
  100. 8.17.3 Suzhou Cefety Bioscience Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Suzhou Cefety Bioscience Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  102. 8.17.5 Suzhou Cefety Bioscience Recent Developments
  103. 8.18 Zhejiang Hengyu Biological
  104. 8.18.1 Zhejiang Hengyu Biological Company Information
  105. 8.18.2 Zhejiang Hengyu Biological Business Overview
  106. 8.18.3 Zhejiang Hengyu Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Zhejiang Hengyu Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  108. 8.18.5 Zhejiang Hengyu Biological Recent Developments
  109. 8.19 Merck
  110. 8.19.1 Merck Company Information
  111. 8.19.2 Merck Business Overview
  112. 8.19.3 Merck Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Merck Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  114. 8.19.5 Merck Recent Developments
  115. 8.20 Charles River Laboratories
  116. 8.20.1 Charles River Laboratories Company Information
  117. 8.20.2 Charles River Laboratories Business Overview
  118. 8.20.3 Charles River Laboratories Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Charles River Laboratories Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  120. 8.20.5 Charles River Laboratories Recent Developments
  121. 8.21 Sartorius
  122. 8.21.1 Sartorius Company Information
  123. 8.21.2 Sartorius Business Overview
  124. 8.21.3 Sartorius Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Sartorius Pharmaceutical and Biopharmaceutical Safety Testing Service Product Portfolio
  126. 8.21.5 Sartorius Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst